Relay Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLAY and other ETFs, options, and stocks.

About RLAY

Relay Therapeutics, Inc. engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo platform is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. 

CEO
Sanjiv K. Patel
CEOSanjiv K. Patel
Employees
261
Employees261
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
261
Employees261

RLAY Key Statistics

Market cap
542.47M
Market cap542.47M
Price-Earnings ratio
-1.33
Price-Earnings ratio-1.33
Dividend yield
—
Dividend yield—
Average volume
2.25M
Average volume2.25M
High today
$3.21
High today$3.21
Low today
$3.03
Low today$3.03
Open price
$3.14
Open price$3.14
Volume
1.62M
Volume1.62M
52 Week high
$10.72
52 Week high$10.72
52 Week low
$1.78
52 Week low$1.78

Analyst ratings

83%

of 12 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.